Bruce Cree, MD, PhD, MAS - Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis

PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast

English - January 20, 2021 23:00 - 18 minutes - ★★★★ - 10 ratings
Science cme medical education cme credits peerview insession inreview neurology cne neuroscience psychiatry Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Orrin Devinsky, MD - Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals

Next Episode: John Ravits, MD - Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies

Go online to PeerView.com/JFZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert neurologist discusses new disease-modifying therapies for multiple sclerosis. Upon completion of this activity, participants should be better able to: Apply the latest efficacy, safety, and tolerability data for approved disease-modifying therapies in individualized management of patients with multiple sclerosis, Discuss emerging data for newly approved disease-modifying therapies for the treatment of multiple sclerosis.